drugset / Trial / NCT03941340
Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Volunteers
NaSingle-groupOpen-labelOther
Summary
Study to Evaluate the Mass Balance and Biotransformation of Single Dose\[14C\] AST2818 in Chinese Healthy Male Volunteers
Timeline
- Start
- 2019-04-08
- Primary completion
- 2019-09-06
- Completion
- 2019-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Firmonertinib | Small molecule | 80 mg | Oral |
Indications
No indication recorded.